Literature DB >> 1656801

MyoD1 protein expression in alveolar soft part sarcoma as confirmatory evidence of its skeletal muscle nature.

J Rosai1, P Dias, D M Parham, D N Shapiro, P Houghton.   

Abstract

A typical case of alveolar soft part sarcoma was found to express in a strong and widespread fashion the marker MyoD1 protein. This nuclear phosphoprotein is the product of a regulatory gene that controls the commitment of a cell to myogenic lineage; it therefore provides strong and perhaps definitive evidence in support of the skeletal muscle nature of this enigmatic neoplasm.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1656801     DOI： 10.1097/00000478-199110000-00008

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN： 0147-5185            Impact factor:   6.394


  18 in total

Review 1.  Alveolar soft part sarcoma: are we at the end or just the beginning of our quest?

Authors:  Sharon W Weiss
Journal:  Am J Pathol       Date:  2002-04       Impact factor: 4.307

2.  A comparison of MyoD1 and fetal acetylcholine receptor expression in childhood tumors and normal tissues: implications for the molecular diagnosis of minimal disease in rhabdomyosarcomas.

Authors:  S Gattenloehner; B Dockhorn-Dworniczak; I Leuschner; A Vincent; H K Müller-Hermelink; A Marx
Journal:  J Mol Diagn       Date:  1999-11       Impact factor: 5.568

3.  Alveolar soft-part sarcoma: can MRI help discriminating from other soft-tissue tumors? A study of the French sarcoma group.

Authors:  Amandine Crombé; Hervé J Brisse; Pauline Ledoux; Leila Haddag-Miliani; Amine Bouhamama; Sophie Taieb; François Le Loarer; Michèle Kind
Journal:  Eur Radiol       Date:  2018-12-17       Impact factor: 5.315

4.  The fetal form of the acetylcholine receptor distinguishes rhabdomyosarcomas from other childhood tumors.

Authors:  S Gattenloehner; A Vincent; I Leuschner; S Tzartos; H K Müller-Hermelink; T Kirchner; A Marx
Journal:  Am J Pathol       Date:  1998-02       Impact factor: 4.307

5.  Alveolar soft part sarcoma presenting as a breast metastasis in a patient with a history of thyroid cancer: a case report.

Authors:  Andrey Bychkov; Pichet Sampatanukul
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

Review 6.  Alveolar soft-part sarcoma: a review and update.

Authors:  A L Folpe; A T Deyrup
Journal:  J Clin Pathol       Date:  2006-11       Impact factor: 3.411

7.  Molecular classification and subtype-specific drug sensitivity research of uterine carcinosarcoma under multi-omics framework.

Authors:  Xiaofan Lu; Liya Zhang; Huiling Zhao; Chen Chen; Yaoyan Wang; Shengjie Liu; Xiao Lin; Yue Wang; Qianyuan Zhang; Tao Lu; Fangrong Yan
Journal:  Cancer Biol Ther       Date:  2018-10-25       Impact factor: 4.742

8.  Alveolar soft part sarcoma associated with lung and brain metastases: A case report.

Authors:  Mingguang Wang; Jinxing Li; Linchun Huan; Fanguo Meng; Qi Pang
Journal:  Oncol Lett       Date:  2016-06-15       Impact factor: 2.967

9.  Myogenic regulatory protein expression in adult soft tissue sarcomas. A sensitive and specific marker of skeletal muscle differentiation.

Authors:  G Tallini; D M Parham; P Dias; C Cordon-Cardo; P J Houghton; J Rosai
Journal:  Am J Pathol       Date:  1994-04       Impact factor: 4.307

Review 10.  Primary alveolar soft part sarcoma of fibula demonstrating ASPL-TFE3 fusion: a case report and review of the literature.

Authors:  Seena C Aisner; Kathleen Beebe; Marcia Blacksin; Neena Mirani; Meera Hameed
Journal:  Skeletal Radiol       Date:  2008-07-02       Impact factor: 2.199
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.